Variants in C-reactive protein and IL-6 genes and susceptibility to obstructive sleep apnea in children: A candidate-gene association study in European American and Southeast European populations

Sleep Medicine

Volumn 15, Issue 2, 2014, Pages 228-235

  Kaditis, Athanasios G ^a   Gozal, David ^b,c   Khalyfa, Abdelnaby ^b,c   Kheirandish Gozal, Leila ^b,c   Capdevila, Oscar Sans ^c   Gourgoulianis, Konstantinos ^d   Alexopoulos, Emmanouel I ^d   Chaidas, Konstantinos ^d   Bhattacharjee, Rakesh ^b,c   Kim, Jinkwan ^b,c   Rodopoulou, Paraskevi ^e   Zintzaras, Elias ^e,f  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF CHICAGO   (United States)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^e UNIVERSITY OF THESSALY   (Greece)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C reactive protein; Genetic association; Inflammation; Interleukin 6; Obstructive sleep apnea; Obstructive sleep disordered breathing

Indexed keywords

C-REACTIVE PROTEIN; GENETIC ASSOCIATION; INFLAMMATION; INTERLEUKIN-6; OBSTRUCTIVE SLEEP APNEA; OBSTRUCTIVE SLEEP-DISORDERED BREATHING;

C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREECE; HAPLOTYPES; HUMANS; INTERLEUKIN-6; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; UNITED STATES;

EID: 84895103936     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2013.08.795     Document Type: Article

References (58)

1. Kaditis A., Kheirandish-Gozal L., Gozal D. Algorithm for the diagnosis and treatment of pediatric OSA: a proposal of two pediatric sleep centers. Sleep Med 2012, 13:217-227.
2. Remmers J.E., deGroot W.J., Sauerland E.K., Anch A.M. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978, 44:931-938.
3. Arens R., Marcus C.L. Pathophysiology of upper airway obstruction: a developmental perspective. Sleep 2004, 27:997-1019.
4. Redline S., Tishler P.V., Tosteson T.D., Williamson J., Kump K., Browner I., et al. The familial aggregation of obstructive sleep apnea. Am J Respir Crit Care Med 1995, 151:682-687.
5. Palmer L.J., Buxbaum S.G., Larkin E., Patel S.R., Elston R.C., Tishler P.V., et al. A whole-genome scan for obstructive sleep apnea and obesity. Am J Hum Genet 2003, 72:340-350.
6. Riha R.L., Brander P., Vennelle M., McArdle N., Kerr S.M., Anderson N.H., et al. Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. Eur Respir J 2005, 26:673-678.
7. Larkin E.K., Patel S.R., Goodloe R.J., Li Y., Zhu X., Gray-McGuire C., et al. A candidate gene study of obstructive sleep apnea in European Americans and African Americans. Am J Respir Crit Care Med 2010, 182:947-953.
8. Castell J.V., Gomez-Lechon M.J., David M., Fabra R., Trullenque R., Heinrich P.C. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990, 12:1179-1186.
9. Lavie L. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 2003, 7:35-51.
10. Tauman R., Ivanenko A., O'Brien L.M., Gozal D. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics 2004, 113:e564-e569.
11. Kaditis A.G., Alexopoulos E.I., Kalampouka E., Kostadima E., Germenis A., Zintzaras E., et al. Morning levels of C-reactive protein in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med 2005, 171:282-286.
12. Zintzaras E., Santos M. Estimating the mode of inheritance in genetic association studies of qualitative traits based on the degree of dominance index. BMC Med Res Methodol 2011, 11:171.
13. Zintzaras E., Santos M. Performance of MAX test and degree of dominance index in predicting the mode of inheritance. Stat Appl Genet Mol Biol 2012, 11. [Article 4].
14. Zintzaras E. The generalized odds ratio as a measure of genetic risk effect in the analysis and meta-analysis of association studies. Stat Appl Genet Mol Biol 2010, 9. [Article 21].
15. Montgomery-Downs H.E., O'Brien L.M., Holbrook C.R., Gozal D. Snoring and sleep-disordered breathing in young children: subjective and objective correlates. Sleep 2004, 27:87-94.
16. Kuczmarski R.J., Ogden C.L., Guo S.S., Grummer-Strawn L.M., Flegal K.M., Mei Z., et al. CDC growth charts for the United States: methods and development. Vital Health Stat 2000, 11(2002):1-190.
17. Ogden C.L., Kuczmarski R.J., Flegal K.M., Mei Z., Guo S., Wei R., et al. Centers for disease control and prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002, 109:45-60.
18. Apostolidou M.T., Alexopoulos E.I., Chaidas K., Ntamagka G., Karathanasi A., Apostolidis T.I., et al. Obesity and persisting sleep apnea after adenotonsillectomy in Greek children. Chest 2008, 134:1149-1155.
19. Gozal D., Capdevila O.S., Kheirandish-Gozal L. Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children. Am J Respir Crit Care Med 2008, 177:1142-1149.
20. Kaditis A., Gozal D., Snow A.B., Kheirandish-Gozal L., Alexopoulos E., Varlami V., et al. Uric acid excretion in North American and Southeast European children with obstructive sleep apnea. Sleep Med 2010, 11:489-493.
21. Popko K., Gorska E., Potapinska O., Wasik M., Stoklosa A., Plywaczewski R., et al. Frequency of distribution of inflammatory cytokines IL-1, IL-6 and TNF-alpha gene polymorphism in patients with obstructive sleep apnea. J Physiol Pharmacol 2008, 59(Suppl. 6):607-614.
22. Qi L., van Dam R.M., Meigs J.B., Manson J.E., Hunter D., Hu F.B. Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. Hum Mol Genet 2006, 15:1914-1920.
23. Qi L., Zhang C., van Dam R.M., Hu F.B. Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals. J Clin Endocrinol Metab 2007, 92:3618-3625.
24. Martinez-Calatrava M.J., Gonzalez-Sanchez J.L., Martinez-Larrad M.T., Perez-Barba M., Serrano-Rios M. Common haplotypes of the C-reactive protein gene and circulating leptin levels influence the interindividual variability in serum C-reactive protein levels. The Segovia study. Thromb Haemost 2007, 98:1088-1095.
25. Kolz M., Koenig W., Muller M., Andreani M., Greven S., Illig T., et al. DNA variants, plasma levels and variability of C-reactive protein in myocardial infarction survivors: results from the AIRGENE study. Eur Heart J 2008, 29:1250-1258.
26. Gallicchio L., Chang H., Christo D.K., Thuita L., Huang H.Y., Strickland P., et al. Single nucleotide polymorphisms in inflammation-related genes and mortality in a community-based cohort in Washington County, Maryland. Am J Epidemiol 2008, 167:807-813.
27. Zintzaras E. The power of generalized odds ratio in assessing association in genetic studies with known mode of inheritance. J Appl Stat 2012, 39:2569-2581.
28. Weir B.S. Genetic data analysis II: methods for discrete population genetic data 1996, Sinauer Associates, Sunderland (MA).
29. Zintzaras E., Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 2008, 61:634-645.
30. Lewis PO, Zaykin D. Genetic data analysis: computer program for the analysis of allelic data. 1.0 (d16c) ed2001.
31. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005, 15:97-98.
32. Zhang X., Liu R.Y., Lei Z., Zhu Y., Huang J.A., Jiang X., et al. Genetic variants in interleukin-6 modified risk of obstructive sleep apnea syndrome. Int J Mol Med 2009, 23:485-493.
33. Riha R.L. Genetic aspects of the obstructive sleep apnoea/hypopnoea syndrome-is there a common link with obesity?. Respiration 2009, 78:5-17.
34. Goldbart A.D., Krishna J., Li R.C., Serpero L.D., Gozal D. Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome. Chest 2006, 130:143-148.
35. Dayyat E., Serpero L.D., Kheirandish-Gozal L., Goldman J.L., Snow A., Bhattacharjee R., et al. Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea. Chest 2009, 135:1142-1149.
36. Kim J., Bhattacharjee R., Dayyat E., Snow A.B., Kheirandish-Gozal L., Goldman J.L., et al. Increased cellular proliferation and inflammatory cytokines in tonsils derived from children with obstructive sleep apnea. Pediatr Res 2009, 66:423-428.
37. Khoury M.J., Little J., Gwinn M., Ioannidis J.P. On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. Int J Epidemiol 2007, 36:439-445.
38. Crawford D.C., Sanders C.L., Qin X., Smith J.D., Shephard C., Wong M., et al. Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 2006, 114:2458-2465.
39. Huang C.C., Chung C.M., Leu H.B., Lin T.H., Hung S.I., Wu T.C., et al. Genetic variation in C-reactive protein in ethnic Chinese population in Taiwan. Eur J Clin Invest 2013, 43:449-456.
40. Kheirandish-Gozal L., Capdevila O.S., Tauman R., Gozal D. Plasma C-reactive protein in nonobese children with obstructive sleep apnea before and after adenotonsillectomy. J Clin Sleep Med 2006, 2:301-304.
41. Villa M.P., Ianniello F., Tocci G., Evangelisti M., Miano S., Ferrucci A., et al. Early cardiac abnormalities and increased C-reactive protein levels in a cohort of children with sleep disordered breathing. Sleep Breath 2012, 16:101-110.
42. Goldbart A.D., Levitas A., Greenberg-Dotan S., Ben Shimol S., Broides A., Puterman M., et al. B-type natriuretic peptide and cardiovascular function in young children with obstructive sleep apnea. Chest 2010, 138:528-535.
43. Floyd-Smith G., Whitehead A.S., Colten H.R., Francke U. The human C-reactive protein gene (CRP) and serum amyloid P component gene (APCS) are located on the proximal long arm of chromosome 1. Immunogenetics 1986, 24:171-176.
44. Crawford D.C., Yi Q., Smith J.D., Shephard C., Wong M., Witrak L., et al. Allelic spectrum of the natural variation in CRP. Hum Genet 2006, 119:496-504.
45. Hage F.G., Szalai A.J. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol 2007, 50:1115-1122.
46. Yasukawa K., Hirano T., Watanabe Y., Muratani K., Matsuda T., Nakai S., et al. Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J 1987, 6:2939-2945.
47. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998, 102:1369-1376.
48. Humphries S.E., Luong L.A., Ogg M.S., Hawe E., Miller G.J. The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001, 22:2243-2252.
49. Vickers M.A., Green F.R., Terry C., Mayosi B.M., Julier C., Lathrop M., et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002, 53:1029-1034.
50. Zintzaras E., Kitsios G., Stefanidis I. Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 2006, 48:700-710.
51. Zintzaras E. Variance estimation of allele-based odds ratio in the absence of Hardy-Weinberg equilibrium. Eur J Epidemiol 2008, 23:323-326.
52. Zintzaras E. Impact of Hardy-Weinberg equilibrium deviation on allele-based risk effect of genetic association studies and meta-analysis. Eur J Epidemiol 2010, 25:553-560.
53. Bender R., Lange S. Adjusting for multiple testing-when and how?. J Clin Epidemiol 2001, 54:343-349.
54. Perneger T.V. What's wrong with Bonferroni adjustments. BMJ 1998, 316:1236-1238.
55. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1990, 1:43-46.
56. Zintzaras E., Lau J. Trends in meta-analysis of genetic association studies. J Hum Genet 2008, 53:1-9.
57. Abecasis G.R., Cherny S.S., Cookson W.O., Cardon L.R. Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002, 30:97-101.
58. Hauser M.A., Li Y.J., Takeuchi S., Walters R., Noureddine M., Maready M., et al. Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage. Hum Mol Genet 2003, 12:671-677.